|
Glaxo starting late-stage study of asthma drug
Businessweek British drugmaker GlaxoSmithKline PLC said Monday that it is starting two late-stage patient studies of an experimental biologic drug as an add-on treatment for patients with severe, uncontrolled asthma. Both studies will compare the safety and … GlaxoSmithKline starts final-stage tests on severe asthma drug GSK Begins Phase lll Program for Mepolizumab in Severe Refractory Asthma GSK starts final-stage tests on severe asthma drug |
View full post on asthma – Google News